Lecture 12 (endocrine)- Exam 6 Flashcards
Insulin with CKD – follow-up
Parathyroid gland
* Located where?
* What does is detect and regulate?
- Located within the thyroid gland
- Detect changes in calcium levels and regulates the release of parathyroid hormone (PTH)
Parathyroid disorders
* What does PTH release trigger? (3)
- Bones to release Ca++
- Kidneys to reabsorb Ca++
- Synthesizes active vitamin D – increases GI Ca++ absorption
Hyperparathyroidism: Secondary
* Increased what? In response to what?
* MC in the setting of what?
* Kidneys not producing what? Not filtering out what?
- Increased PTH in response to low calcium
- MC in the setting of CKD
- Kidneys not producing calcitriol; not filtering out phosphorus
What are the hypercalemia sxs? What about the EKG?
Treatment – Primary hyperparathyroidism
* What is definitive therapy?
Surgical removal as definitive therapy
Treatment – Primary hyperparathyroidism
* All symptomatic patients and asymptomatic patients who meet the following criteria (7)
- ≤ 50 years of age
- Serum calcium levels > 1mg/dL above upper limit of normal
- Calcinuria (urine calcium levels >250 – 300 mg/24h)
- Creatinine clearance < 60 ml/min/1.73m2
- Osteoporosis (T-score < -2.5)
- Nephrolithiasis / nephrocalcinosis
- Desire for surgery
Treatment – Primary hyperparathyroidism
* Non-surgical candidates with symptoms of hypercalemia: What are the goals?
Goals: reduce serum calcium levels and/or improve bone mineral density
Treatment – Primary hyperparathyroidism
* What do you give for Patients with hypercalcemia and normal bone mineral density?
Calcimimetics (Cinacalcet)
Calcimimetics (Cinacalcet)
* How does Calcimietics work? (What does it bind, increase, decreade and what does it not impact)?
- Bind calcium-sensing receptor in the parathyroid gland
- Increase the sensitivity to calcium
- Decreased secretion of PTH
- Decreased serum calcium levels
- Does not impact bone density
Treatment – Primary hyperparathyroidism
* What do you give to Patients with osteoporosis at risk of fracture?
Bisphosphonates
Osteoporosis treatment – 1st line therapy: Bisphosphonates
* What is the MOA?
Reduce bone resorption by:
* Stimulating osteoclast apoptosis
* Decrease cholesterol synthetic pathway – decreases osteoclast function
Bisphosphonates
* Bioavailability? Worse with what?
* Amount absorbed
Bioavailability poor - < 1%
* Worse with concomitant food intake
Amount absorbed
* 50% eliminated renally
* 50% remains for months to years
Bisphosphonate side effects
* What are the SE?
Bisphosphonates: Oral (alendronate, risedronate)
* Take on what?
* Full what?
* Remain what?
- Take on empty stomach in the morning – increases poor bioavailability
- Full glass of water
- Remain upright for at least 30 minutes
Bisphosphonates
* IV verison?
Zoledronic acid
Bisphosphonates
* Not recommended for who?
Not recommended for creatinine clearance < 30 ml/min/1.73 m2
Secondary Hyperparathyroidism causing hyperphosphatemia
Treatment-secondary hyperphosphatemia
* What is first line?
Dietary phosphate restriction – 900mg phosphate/day
Treatment-secondary hyperphosphatemia
* What is second line? Who is this for?
Persistent phosphate > 5.5 mg/dL with dietary restriction
* Phosphate binders
* Calcium carbonate / calcium acetate
* Sevelamer (Renagel): Bind phosphate through Ion exchange
Hypoparathyroidism
* What is the MCC?
* What are some other causes?
- MCC is surgical: Thyroid, parathyroid, or neck surgery
- Immune-mediated destruction of parathyroid glands
- Genetic disorders – DiGeorge syndrome
Hypoparathyroidism
* What are the levels of calcium, PTH, phosphorus and magnesium?
Low calcium
* Low or inappropriately normal parathyroid hormone (PTH)
* High phosphorus
* Normal magnesium